• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多产妇女卵巢癌发病率——芬兰一项基于人群的研究

Incidence of ovarian cancer of grand multiparous women--a population-based study in Finland.

作者信息

Hinkula Marianne, Pukkala Eero, Kyyrönen Pentti, Kauppila Antti

机构信息

Department of Obstetric and Gynaecology, University of Oulu, PL 24, FIN-90029 OYS, Finland.

出版信息

Gynecol Oncol. 2006 Oct;103(1):207-11. doi: 10.1016/j.ygyno.2006.02.025. Epub 2006 Apr 3.

DOI:10.1016/j.ygyno.2006.02.025
PMID:16595149
Abstract

OBJECTIVES

Parity is known to induce protective effects on ovarian cancer. This study aimed to evaluate how far upon births the protection reaches, the effect of age at first birth, the interval between births in the whole population and the length of time from the first to the last birth and from the last birth to cancer among postmenopausal women.

METHOD

The population-based cohort consisted of 87,929 grand multiparous (GM) women, i.e. women with at least 5 deliveries. Standardised incidence ratios (SIRs) were calculated by dividing the number of observed cancer cases by the expected number based on the national incidence rates, both extracted from the population-based Finnish Cancer Registry. Conditional logistic regression for the case-control design nested in the GM cohort was used to estimate proportional hazards by different factors.

RESULTS

The SIR for ovarian cancer among GM women was low (418 cases; SIR 0.64, 95% confidence interval 0.58-0.69). Further births over five did not give additional protection. The relative risk did not vary significantly by age at first birth or interval between the births in any histological subtype.

CONCLUSION

The risk of ovarian cancer was low in all GM women no matter how many children and at which ages they had delivered or contracted cancer.

摘要

目的

已知生育次数对卵巢癌具有保护作用。本研究旨在评估这种保护作用在生育后能持续多久,首次生育年龄的影响,整个人口中生育间隔的影响,以及绝经后女性从首次生育到最后一次生育的时间长度和从最后一次生育到患癌的时间长度。

方法

基于人群的队列由87929名多产妇女(GM)组成,即至少生育5次的妇女。标准化发病率(SIR)通过将观察到的癌症病例数除以基于国家发病率的预期病例数来计算,两者均取自基于人群的芬兰癌症登记处。在GM队列中嵌套的病例对照设计采用条件逻辑回归来估计不同因素的比例风险。

结果

GM妇女中卵巢癌的SIR较低(418例;SIR 0.64,95%置信区间0.58 - 0.69)。超过5次的进一步生育并未提供额外保护。在任何组织学亚型中,相对风险在首次生育年龄或生育间隔方面均无显著差异。

结论

所有GM妇女患卵巢癌的风险都较低,无论她们生育了多少子女、在什么年龄生育或患癌。

相似文献

1
Incidence of ovarian cancer of grand multiparous women--a population-based study in Finland.多产妇女卵巢癌发病率——芬兰一项基于人群的研究
Gynecol Oncol. 2006 Oct;103(1):207-11. doi: 10.1016/j.ygyno.2006.02.025. Epub 2006 Apr 3.
2
Timing of pregnancy and the risk of epithelial ovarian cancer.妊娠时间与上皮性卵巢癌风险
Cancer Epidemiol Biomarkers Prev. 2003 Jan;12(1):42-6.
3
Breast cancer risk in monozygotic and dizygotic female twins: a 20-year population-based cohort study in Finland from 1976 to 1995.单卵和双卵双胞胎女性患乳腺癌的风险:一项基于芬兰1976年至1995年20年人群的队列研究。
Cancer Epidemiol Biomarkers Prev. 1999 Mar;8(3):271-4.
4
Time since last birth and the risk of ovarian cancer.上次生育后的时间与卵巢癌风险
Gynecol Oncol. 2001 May;81(2):233-6. doi: 10.1006/gyno.2001.6136.
5
Beyond parity: association of ovarian cancer with length of gestation and offspring characteristics.超越均等:卵巢癌与妊娠时长及子代特征的关联
Am J Epidemiol. 2009 Sep 1;170(5):607-14. doi: 10.1093/aje/kwp185. Epub 2009 Jul 28.
6
Grand multiparity and incidence of endometrial cancer: a population-based study in Finland.多产与子宫内膜癌发病率:芬兰一项基于人群的研究
Int J Cancer. 2002 Apr 20;98(6):912-5. doi: 10.1002/ijc.10267.
7
The risk of cancer and the role of parity among women with endometriosis.子宫内膜异位症女性患癌风险及生育状况的作用。
Hum Reprod. 2007 Nov;22(11):3021-6. doi: 10.1093/humrep/dem209. Epub 2007 Sep 13.
8
Gender of offspring and maternal risk of invasive epithelial ovarian cancer.子代性别与上皮性卵巢癌的母亲发病风险
Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2314-20. doi: 10.1158/1055-9965.EPI-07-0645.
9
Mortality from breast, endometrial and ovarian cancers among grand multiparous women in Taiwan.台湾多产妇女中乳腺癌、子宫内膜癌和卵巢癌的死亡率。
Aust N Z J Obstet Gynaecol. 2011 Dec;51(6):548-52. doi: 10.1111/j.1479-828X.2011.01360.x. Epub 2011 Sep 12.
10
A prospective study of the transient decrease in ovarian cancer risk following childbirth.一项关于分娩后卵巢癌风险短暂降低的前瞻性研究。
Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2508-13. doi: 10.1158/1055-9965.EPI-06-0242.

引用本文的文献

1
Primary Fallopian Tube Carcinoma Presenting as a Broad Ligament Fibroid: A Rare Case.表现为阔韧带肌瘤的原发性输卵管癌:1例罕见病例
Cureus. 2023 Nov 20;15(11):e49142. doi: 10.7759/cureus.49142. eCollection 2023 Nov.
2
In vitro chemo-preventive efficacy of synthetic progestin Norethindrone in human epithelial ovarian cancer.体外合成孕激素左炔诺孕酮对人卵巢上皮性癌细胞的化学预防作用。
Med Oncol. 2023 Jun 3;40(7):195. doi: 10.1007/s12032-023-02061-2.
3
Pregnancy duration and ovarian cancer risk: A 50-year nationwide cohort study.妊娠持续时间与卵巢癌风险:一项长达 50 年的全国性队列研究。
Int J Cancer. 2022 Nov 15;151(10):1717-1725. doi: 10.1002/ijc.34192. Epub 2022 Jul 12.
4
Estrogen combined with progesterone decreases cell proliferation and inhibits the expression of Bcl-2 via microRNA let-7a and miR-34b in ovarian cancer cells.雌激素联合孕激素可降低卵巢癌细胞的细胞增殖,并通过微小RNA let-7a和miR-34b抑制Bcl-2的表达。
Clin Transl Oncol. 2014 Oct;16(10):898-905. doi: 10.1007/s12094-014-1166-x. Epub 2014 Mar 19.
5
Hormonal and reproductive risk factors for epithelial ovarian cancer by tumor aggressiveness.按肿瘤侵袭性分析上皮性卵巢癌的激素和生殖风险因素。
Cancer Epidemiol Biomarkers Prev. 2013 Mar;22(3):429-37. doi: 10.1158/1055-9965.EPI-12-1183-T. Epub 2013 Jan 10.
6
Genetic and epigenetic alterations of steroidogenic factor‑1 in ovarian tumors.甾体生成因子-1 在卵巢肿瘤中的遗传和表观遗传改变。
Int J Oncol. 2013 Feb;42(2):627-34. doi: 10.3892/ijo.2012.1758. Epub 2012 Dec 28.
7
Recent progress in the diagnosis and treatment of ovarian cancer.卵巢癌的诊断与治疗新进展。
CA Cancer J Clin. 2011 May-Jun;61(3):183-203. doi: 10.3322/caac.20113. Epub 2011 Apr 26.